Nancy Ann Simonian

M.D. | Neurology


  Millennium Pharmaceuticals, 40 Landsdowne St, Cambridge
     Massachusetts, 02139
  617-551-3612    Maps & Directions
Nancy Ann Simonian is a Cambridge, Massachusetts based neurologist who is specialized in Neurology. Her current practice location is Millennium Pharmaceuticals, 40 Landsdowne St, Cambridge. Patients can reach her at 617-551-3612. Nancy Ann Simonian is M.D. in Neurology and her NPI number (Unique professional ID assigned by NPPES) is 1386712123.
Nancy Ann Simonian specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Nancy Ann Simonian speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Nancy Ann Simonian
Specialization: Neurology
Gender:Female
Credentials: M.D.
Practice Address:Millennium Pharmaceuticals, 40 Landsdowne St, Cambridge,
Massachusetts, 02139
Phone:617-551-3612
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1386712123
NPI Enumeration Date: 01 Dec, 2006
NPI Last Update On: 08 Jul, 2007

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Nancy Ann Simonian
61 Old Sudbury Rd,
Wayland, Massachusetts
Zip: 01778-1808
Phone Number: 617-551-3612
Patients can reach Nancy Ann Simonian at Millennium Pharmaceuticals, 40 Landsdowne St, Cambridge, Massachusetts or can call to book an appointment on 617-551-3612.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.